Login
Toggle navigation
Videos
Categories
Trending
4D Pharma raises $40 million - Duncan Peyton, CEO, 4D Pharma
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
4D Pharma raises $40 million in a Nasdaq listing
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:00:00
Destiny Pharma's nasal spray project already delivering "more than hoped for" - Neil Clark , CEO, Destiny Pharma
00:10:00
Maria Pope, CEO of Portland General Electric (PGE), champions the belief in Portland through her leadership and vision.
00:10:00
Disclosure: Securities and Advisory Services through M Holdings Securities and Eslick Financial Group
00:10:00
Michael Albanese Discusses H2Flow's Customized Water Treatment Solutions for Mining
00:10:00
Mastering Financial Planning Interviews: Key Qualities and Strategies
00:10:00
Mapping XY Data in Excel with ArcGIS for Excel Add-In
00:10:00
Caribbean Utilities Company, Ltd. (TSX:CUP.U) is featured in a video filmed on April 15, 2016, accessible via their official website.
00:10:00
Comparing Donor-Advised Funds and Qualified Charitable Distributions | Mary Grace Graniero - FINANCIAL PLANNER of Howe & Rusling, Inc.
00:10:00
Investing for retirement made easier | Ron Peyton,CEO and executive chairman, CIT Callan International Equity Fund
00:10:00
VC Firm committed to standing in their founder's corner|Leah Solivan,General Partner,Fuel Capital
00:10:00
They invest and support founders from seed until the later stages success|Teddie Wardi,Managing Director,Insight Partners
00:10:00
Alignment of interests in our view is the key to successful private equity investing|Aaron Sack,Head,Morgan Stanly Capital Partners